undamentalytics Newsletter
Sign in

Encompass Health Corp income statement

In fiscal 2025, Encompass Health Corp reported revenue of $5.94bn, up 10.5% on the year before and net income of $566m, or $5.54 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3,6433,9144,2774,6053,5664,0154,3494,8015,3735,9356,338
General and administrative133172220247152170154202209236249
Operating income588578555612564560540————
Interest expense172154147160184164176144137123127
Income before tax4824964935623535054516077509531,066
Income tax16414611911675102100132150193219
Net income248271292359284412271352456566644
Diluted EPS$2.59$2.84$2.93$3.61$2.85$4.11$2.70$3.47$4.46$5.54$6.41
Diluted shares (average)100m99m100m99m100m100m100m101m102m102m101m
EBITDA761762755831767779783————

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ARDT vs EHCCYH vs EHCEHC vs MDEHC vs THC

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Encompass Health Corp's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Encompass Health Corp.